Center Star Asset Management, LLC Gilead Sciences, Inc. Call Options Transaction History

Center Star Asset Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $1.54 Million - $1.76 Million	-25,700 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $1.71 Million - $1.94 Million	-30,100 Reduced 53.94%	25,700 $1.96 Million
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $360,180 - $452,864	-5,800 Reduced 9.42%	55,800 $4.17 Million
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $2.82 Million - $3.28 Million	39,000 Added 172.57%	61,600 $379,000
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $1.5 Million - $1.83 Million	20,600 Added 1030.0%	22,600 $41,000
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $142,300 - $167,040	2,000	2,000 $4,000

1,968

996M

10.5M

9.85M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $123B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.